Sort
34,240 grants matching “atherosclerosis”
Pediatric Ambulatory Blood Pressure Trajectory and Brain Health in Midlife
$691,667Shaoyong Su · Augusta University · R01 · FY2022 · HL
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
$691,662Jeffrey J Goldberger · University Of Miami School Of Medicine · R01 · FY2022 · HL
Developmental stuttering: Population-based genetic discovery
$691,626Jennifer Below · Vanderbilt University Medical Center · R01 · FY2021 · DC
Mechanosensors that detect and treat Lung Fibrosis
$691,620Thomas Harrison Barker · Georgia Institute Of Technology · R01 · FY2015 · HL
Immune function and the risk of cvd among HIV infected and uninfected veterans
$691,563Matthew S Freiberg · Vanderbilt University Medical Center · R01 · FY2017 · HL
Carotid Intraplaque Hemorrhage: MRI of Therapeutic Response and Clinical Sequelae
$691,543Chun Yuan · University Of Washington · R01 · FY2012 · HL
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
$691,529Rozenn Lemaitre · University Of Washington · R01 · FY2022 · HL
Comprehensive Magnetic Resonance in PAD
$691,422Christopher M Kramer · University Of Virginia · R01 · FY2018 · HL
Metabolic Regulation of Inflammatory Immune Responses in Cardiovascular Disease
$691,354Cornelia M Weyand · Vanderbilt University Medical Center · P01 · FY2016 · HL
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease
$691,315Brian H Annex · University Of Virginia · R01 · FY2017 · HL
Structural basis for cardioprotective HDL
$691,232Jay W Heinecke · University Of Washington · R01 · FY2022 · HL
Structural basis for cardioprotective HDL
$691,232Jay W Heinecke · University Of Washington · R01 · FY2023 · HL
Structural basis for cardioprotective HDL
$691,232Jay W Heinecke · University Of Washington · R01 · FY2021 · HL
ACHIEVE P1 - HTN
$691,226Robert D Brook · Wayne State University · P50 · FY2022 · MD
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease
$691,170Brian H Annex · University Of Virginia · R01 · FY2014 · HL
Rare variants and NHLBI traits in deeply phenotyped cohorts
$691,102Bruce M Psaty · University Of Washington · U01 · FY2017 · HL
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL
$691,087Miguel Valderrabano · Methodist Hospital Research Institute · R33 · FY2024 · HL
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL
$691,087Miguel Valderrabano · Methodist Hospital Research Institute · R33 · FY2025 · HL
Inactivity, sedentary behavior, and the risk for Alzheimerâs disease in middle aged to older adults
$690,985David Raichlen · University Of Southern California · R01 · FY2022 · AG
Epigenetics of Successful Aging
$690,942Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · HL
Molecular mechanisms relating Poldip2 to endothelial permeability
$690,886Kathy K Griendling · Emory University · R01 · FY2025 · HL
Cardiovascular Institutional Research Fellowship
$690,856Francois M Abboud · University Of Iowa · T32 · FY2016 · HL
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
$690,826Jeffrey J Goldberger · University Of Miami School Of Medicine · R01 · FY2023 · HL
Role of Complement Activation in Severe COVID-19
$690,773Xuebin Qin · Tulane University Of Louisiana · R01 · FY2022 · HL
Metabolomics of subclinical and clinical cardiovascular disease
$690,734Dean P. Jones · Emory University · P20 · FY2012 · HL